COMMUNIQUÉS West-GlobeNewswire

Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026
28/10/2026
WATERTOWN, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
28/10/2026
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and [...]
Nordic Naturals Joins Eudēmonia Summit as Featured Partner and Exhibitor, Hosting Panel on Omega-3s and Healthy Aging
28/10/2026
Watsonville, CA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals , the #1 selling omega-3 brand in the U.S.‡, today announced it will be a featured partner and brand presenter at the Eudēmonia Summit, a science-based [...]
Revenue for the nine months ended September 2026
28/10/2026
Revenue at end September 2026 of €4,051m, up +4.7% on an organic basis compared with the same period in 2025 All activities and regions contributed to revenue growth, supported by favourable volume, price and case mix [...]
Chiffre d’affaires au Septembre 2026
28/10/2026
Le chiffre d’affaires à fin septembre 2026 s’établit à €4 051m , en progression de +4,7% en base organique par rapport à la même période de 2025 L’ensemble des activités et des régions contribue à la croissance du [...]
Major shareholder announcement - BlackRock, Inc.
28/10/2026
ANNOUNCEMENT NO. 323 28 October 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 26 October 2026, BlackRock, Inc. increased [...]
RYBREVANT®▼ (amivantamab) sous-cutané affiche un taux de réponse objective de 77 pour cent en traitement de première ligne chez des patients atteints de certaines formes avancées de cancer de la tête et du cou
28/10/2026
Des réponses complètes ont été observées chez 14 pour cent des patients atteints d’un carcinome épidermoïde de la tête et du cou (CETC) autre qu’un carcinome épidermoïde de l’oropharynx (CEOP) associé au papillomavirus [...]
NVision Unveils First Manufacturable Molecular Qubit, Breakthrough Validated in Peer-Reviewed Nature Paper
28/10/2026
Partners with HyperLight to integrate thin-film molecular qubits onto advanced photonic integrated circuits, paving the way for a new architecture that delivers quantum computing at scale NVision Unveils First [...]
BayCare Selected as a National Best Workplace for Women
28/10/2026
CLEARWATER, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Great Place to Work® and Fortune magazine have selected BayCare for the 2026 Fortune Best Workplaces for Women™ list, marking the sixth time BayCare has earned a spot [...]
AdipoPharma lance la phase 1b des essais cliniques du peptide PATAS chez des patients atteints de diabète de type 2
28/10/2026
Les premiers participants atteints de diabète de type 2 ont reçu leur première dose dans le cadre d’une étude à doses multiples croissantes (MAD) évaluant le premier sensibilisateur à l’insuline de sa catégorie [...]
$20,000 donated by Saskatchewan Blue Cross to six local organizations
28/10/2026
SASKATOON, Saskatchewan, Oct. 28, 2026 (GLOBE NEWSWIRE) -- A simple click can make a big impact. This year, those clicks translated into $20,000 in funding for six Saskatchewan organizations. Through Saskatchewan Blue [...]
Novato-based Live Oaks Wellness encourages year-round prevention with family engagement and community-based prevention efforts for substance abuse
28/10/2026
National Substance Abuse Prevention Month Goes Beyond Addiction Awareness NOVATO, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- The month of October celebrates an important national recognition that goes beyond just [...]
Flexi Yoga App Launches Personalized Flexibility and Mobility App
28/10/2026
New Flexi Yoga App Turns a Short Quiz Into a Daily Stretching and Mobility Routine NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Flexi Yoga has launched a personalized wellness app designed to improve flexibility, [...]
Medicana Health Group Introduces Digital Twin-Based Dental Treatment Planning
28/10/2026
Medicana Health Group ’s Associate Professor İlhan Metin Dağsuyu explains how virtual models can help patients understand proposed dental treatment while keeping natural teeth and function at the centre of decisions. [...]
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
28/10/2026
Research presented at ASRM 2026 Scientific Congress & Expo highlights the importance of early engagement and personalized support in helping patients navigate fertility care NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE [...]
DoStance App Launches Personalized Posture App With Guided Daily Exercises
28/10/2026
New App Turns a Short Quiz Into a Daily Posture Routine for Desk Workers NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- DoStance has launched a personalized posture and wellness app that focuses on short, guided exercises [...]
Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer
28/10/2026
Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing the risk of death by [...]
Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal of Chronic Wound Care Management & Research
28/10/2026
Published multicenter clinical trial data demonstrate higher wound closure rates and greater wound area reduction with XWRAP® plus standard of care compared with standard of care alone in patients with chronic diabetic [...]
Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine
28/10/2026
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Vivex [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum